Bixiye
Lyrica (pregabalin) Savella (milnacipran) - Commercial
Step Therapy, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Natiijooyinka Raadinta
Soo bandhiga 1401 - 1410 ee natiijooyinka 3685
Bixiye
Furoscix® (furosemide) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2024
Bixiye
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Commercial
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Urinary Incontinence - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Tezspire® (tezepelumab-ekko) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Gabapentin ER (extended-release) - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Lyrica and Savella - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
QP56-23 Provider Press: Q2 2023
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2023
Bixiye
QP57-23 Reimbursement Update
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2023
Bixiye
QP58-23 Value Code Format Requirements for Minnesota Health Care Programs
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2023